解读成人对人乳头瘤病毒及人乳头瘤病毒疫苗的知识与观点以促进即时接种
这项调查研究纳入2020年9月1日至2021年5月19日在波士顿医疗中心耳鼻咽喉科门诊寻求常规门诊治疗的18至45岁患者,评估对人乳头瘤病毒(HPV)与口咽鳞状细胞癌(OPSCC)关联的知晓情况及既往接种疫苗的可能性。271份调查纳入分析,基线接种率为26.6%(男性10.6%,女性37.9%),仅23.3%了解HPV感染与OPSCC的关系。知晓HPV与癌症及HPV与OPSCC的关联与既往接种可能性增加相关。
要点
- 271名受访者中仅23.3%了解HPV感染与OPSCC的关系。
- 基线接种率总体26.6%,男性10.6%,女性37.9%。
- 知晓HPV与OPSCC关联者既往接种可能性更高(OR 3.7)。
核心结论
- 多数受访者不知道HPV可导致OPSCC。
- 了解HPV导致OPSCC与既往接种疫苗可能性增加相关。
- 多数受访者未从医疗从业者处获知该关系。
- 针对未接种成人的靶向教育结合即时接种可能是提高成人HPV疫苗接种率的创新策略。
研究设计与样本
- 调查研究,纳入2020年9月1日至2021年5月19日在波士顿医疗中心耳鼻咽喉科门诊寻求常规门诊治疗的18至45岁患者。
- 共405名患者接受调查,288名(71.1%)应答,其中271份(94.1%)调查纳入分析。
- 纳入分析者中158名(58.3%)为女性,中位年龄29岁(IQR 24-35岁)。
主要发现
- 基线接种率总体为26.6%(72例),男性为10.6%(12/113),女性为37.9%(60/158)。
- 了解HPV感染与OPSCC关系者63/271(23.3%),知道HPV相关OPSCC是最常见HPV相关癌症类型者9/121(7.4%)。
- 女性较男性更可能既往接种(OR 6.5,95%CI 3.0-13.9)、更知晓HPV导致癌症(OR 3.7,95%CI 1.9-7.1)、更可能从医疗从业者处听说HPV和HPV疫苗(OR 2.6,95%CI 1.2-5.7)。
- 知晓HPV与癌症关系及HPV与OPSCC关系与既往接种可能性增加相关(HPV与癌症:OR 4.1,95%CI 1.8-9.5;HPV与OPSCC:OR 3.7,95%CI 1.8-7.6)。
- 156名未接种参与者中,98名男性中12名(12.2%)和131名女性中7名(5.3%)接受了即时接种。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Human papillomavirus (HPV) vaccination rates remain significantly below rates for other common childhood vaccines, which has implications for future rates of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC). OBJECTIVE: To assess whether individuals who were aware of the association between HPV and OPSCC would be more likely to have been previously vaccinated. DESIGN, SETTING, AND PARTICIPANTS: This survey study included patients aged 18 to 45 years who sought routine outpatient care at the otolaryngology clinic at Boston Medical Center from September 1, 2020, to May 19, 2021. A survey (HPV-Associated Head and Neck Cancer Epidemiology, Awareness and Demographics) [HEAD]) composed of validated questions to assess patient knowledge of HPV and HPV vaccination and barriers to vaccination was delivered to participants. The survey was paired with a novel point-of-care vaccination program housed within an otolaryngology department. MAIN OUTCOMES AND MEASURES: The main outcome was prevalence of knowledge of the relationship between HPV infection and OPSCC based on survey responses. The association of knowledge of HPV-associated OPSCC with likelihood of having been vaccinated was assessed in the overall cohort and by demographic characteristics using multivariate logistic regression. RESULTS: Of 405 patients given the survey, 288 (71.1%) responded. Of these patients, 271 (94.1%) had surveys included; 158 (58.3%) were female, and median age was 29 years (IQR, 24-35 years). The baseline vaccination rate in the surveyed population was low (26.6%; n = 72) overall (10.6% among men [12 of 113]; 37.9% among women [60 of 158]). Few participants understood the relationship between HPV infection and OPSCC (63 of 271 [23.3%]) or that HPV-associated OPSCC is the most common HPV-associated cancer type (9 of 121 [7.4%]). Compared with men, women were more likely to have been previously vaccinated (odds ratio [OR], 6.5; 95% CI, 3.0-13.9), more aware that HPV causes cancer (OR, 3.7; 95% CI, 1.9-7.1), and more likely to have heard about HPV and HPV vaccination from their health care practitioner (OR, 2.6; 95% CI, 1.2-5.7). Knowledge of the relationship between HPV infection and cancer and between HPV and OPSCC was associated with increased likelihood of having been vaccinated (HPV and cancer: OR, 4.1 [95% CI, 1.8-9.5]; HPV and OPSCC: OR, 3.7 [95% CI, 1.8-7.6]). Among 156 unvaccinated participants, 12 of 98 men (12.2%) and 7 of 131 women (5.3%) received point-of-care vaccination. CONCLUSIONS: Most participants in this survey study were unaware that HPV causes OPSCC. Understanding that HPV causes OPSCC was associated with increased likelihood of having been vaccinated. However, most patients surveyed were not informed of this relationship by their health care practitioners. Targeted education aimed at unvaccinated adults establishing the relationship between HPV infection and OPSCC, paired with point-of-care vaccination, may be an innovative strategy for increasing HPV vaccination rates in adults.
引用
- Bloom JC, Kaufmann N, Koss S, et al. Deciphering Knowledge and Opinions of Human Papillomavirus and Human Papillomavirus Vaccination for Facilitation of Point-of-Care Vaccination in Adults. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 37651109. doi:10.1001/jamaoto.2023.2073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。